All News - Latest Health News and Updates | Watchdoq

STAT+: Bhattacharya demures on his view on Trump’s slashing of NIH indirect costs

President Trump's nominee to lead the NIH, Jay Bhattacharya, demurred on his view on Trump’s move to slashi NIH indirect cost payments to universities and other instituions.

Read More

STAT+: Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price

Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers chase market share.

Read More

First Generics for Low-Dose Rivaroxaban Get FDA Approval

(MedPage Today) -- The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday. Rivaroxaban 2.

Read More

Who Is Trump's New Doctor?

(MedPage Today) -- President Trump's new physician is Sean Barbabella, DO, a Navy emergency physician who served in Afghanistan and Iraq, and has "extensive combat trauma experience," according to re

Read More

How Springing Forward to Daylight Saving Time Could Affect Your Health

(MedPage Today) -- Most of America "springs forward" Sunday for daylight saving time and losing that hour of sleep can do more than leave you tired and cranky the next day.

Read More

Biologic May Spark Catch-Up Growth in Kids With Eczema

(MedPage Today) -- SAN DIEGO -- Biologic treatment for atopic dermatitis appeared to improve growth trajectories for younger children, a trial analysis showed.

Read More

Trump’s Nominee for N.I.H. Chief Faces Questions From Senators

Jay Bhattacharya, a health economist, gained prominence during the Covid pandemic when he argued against lockdowns.

Read More

How the race for the next obesity drug is shaping up

And other biotech news stories you need to read, brought to you by The Readout.

Read More

The mixed conservative response to Trump’s health moves

And more health news stories you need to read.

Read More

STAT+: Pharmalittle: We’re reading about lower Wegovy prices, a dispute over Merck’s Keytruda, and more

Novo Nordisk plans to offer its Wegovy weight loss drug at a reduced cost of $499 per month for cash-paying customers in the U.S.

Read More
Health News